CSat Investment Advisory’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

CSat Investment Advisory’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,219	Closed	-$65K	–	1010
2020 Q3	$65K	Buy	1,219 +150	+14%	+$8.93K	0.01%	627
2020 Q2	$62K	Sell	1,069 -942	-47%	-$50.6K	0.01%	644
2020 Q1	$79K	Sell	2,011 -266	-12%	-$15.6K	0.02%	399
2019 Q4	$135K	Sell	2,277 -961	-30%	-$51.7K	0.04%	301
2019 Q3	$172K	Buy	3,238 +568	+21%	+$29.1K	0.05%	227
2019 Q2	$136K	Buy	+2,670	New	+$124K	0.05%	246

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

CSat Investment Advisory's SYNH Position: Q4 2020 in Review

CSat Investment Advisory sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 1,219 shares — an estimated $65K sold.

CSat Investment Advisory first reported a position in SYNH in Q2 2019 and held it in 6 quarters. The position peaked at $172K in Q3 2019. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

CSat Investment Advisory reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
CSat Investment Advisory sold 1,219 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $65K.
CSat Investment Advisory first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2019 and held it in 6 quarters.
CSat Investment Advisory's Syneos Health, Inc. Class A Common Stock position peaked at $172K in Q3 2019.
313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.